The overexpression of Sirtuin3 in MTP+/− mice significantly reduced the acetylation of MTP as compared with β-galactosidase controls and increased mitochondrial fatty acid oxidation and reduced hepatic steatosis, CD68 and serum ALT levels [26]. Here, CD68 is linked to fatty liver disease.